Tandem Diabetes Care Inc
LSE:0M0F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
LSE:0M0F
|
US |
|
A
|
Adevinta ASA
OTC:ADEVF
|
NO |
|
SK Inc
KRX:034730
|
KR |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
8
|
8x8 Inc
DUS:EGT
|
US |
|
V
|
Volkswagen AG
OTC:VLKPF
|
DE |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
OTC:MURGF
|
DE |
|
M
|
Mercialys SA
LSE:0IQU
|
FR |
Wall St Price Targets
0M0F Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for 0M0F is 29.38 USD with a low forecast of 15.62 USD and a high forecast of 52.37 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0M0F's stock price target?
Price Target
29.38
USD
According to Wall Street analysts, the average 1-year price target for 0M0F is 29.38 USD with a low forecast of 15.62 USD and a high forecast of 52.37 USD.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
14%
The compound annual growth rate for Gross Profit over the next 5 years is 14%.
